首页> 外文期刊>Journal of the American Chemical Society >Crystal Structures of Salinosporamide A(NPI-0052)and B (NPI-0047)in Complex with the 20S Proteasome Reveal Important Consequences of beta-Lactone Ring Opening and a Mechanism for Irreversible Binding
【24h】

Crystal Structures of Salinosporamide A(NPI-0052)and B (NPI-0047)in Complex with the 20S Proteasome Reveal Important Consequences of beta-Lactone Ring Opening and a Mechanism for Irreversible Binding

机译:Salinosporamide A(NPI-0052)和B(NPI-0047)与20S蛋白酶复合物中的晶体结构揭示了β-内酯开环的重要后果和不可逆结合的机制

获取原文
获取原文并翻译 | 示例
           

摘要

The crystal structures of the yeast 20S proteasome core particle(CP)in complex with Salinosporamides A(NPI-0052;1)and B(4)were solved at <3 A resolution.Each ligand is covalently bound to Thr1O~gamma via an ester linkage to the carbonyl derived from the beta-lactone ring of the inhibitor.In the case of 1,nucleophilic addition to the beta-lactone ring is followed by addition of C-3O to the chloroethyl group,giving rise to a cyclic ether.The crystal structures were compared to that of the omuralide/CP structure solved previously,and the collective data provide new insights into the mechanism of inhibition and irreversible binding of 1.Upon opening of the beta-lactone ring,C-3O assumes the position occupied by a water molecule in the unligated enzyme and hinders deacylation of the enzyme-ligand complex.Furthermore,the resulting protonation state of Thr1NH_2 deactivates the catalytic N-terminus.
机译:酵母20S蛋白酶体核心颗粒(CP)与盐孢子酰胺A(NPI-0052; 1)和B(4)的晶体结构在<3 A的分辨率下分离。每个配体通过酯共价键合到Thr10-γ在1的情况下,亲核加成至β-内酯环,然后将C-3O加至氯乙基,形成环醚。将晶体结构与先前解决的omuralide / CP结构进行了比较,集体数据为1的抑制和不可逆结合的机理提供了新的见解.β-内酯环打开后,C-3O占据了未连接的酶中的水分子阻碍了酶-配体复合物的去酰化作用。此外,所得的Thr1NH_2质子化状态使催化的N末端失活。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2006年第15期|p.5136-5141|共6页
  • 作者单位

    Contribution from the Ludwig-Maximilians-University of Munich,Butenandtstr.5,Building B,81377 Munich,Germany,Max Planck Institute for Biochemistry,D-82152 Martinsried,Germany,and Nereus Pharmaceuticals,Inc.,10480 Wateridge Circle,San Diego,California;

    Contribution from the Ludwig-Maximilians-University of Munich,Butenandtstr.5,Building B,81377 Munich,Germany,Max Planck Institute for Biochemistry,D-82152 Martinsried,Germany,and Nereus Pharmaceuticals,Inc.,10480 Wateridge Circle,San Diego,California;

    Contribution from the Ludwig-Maximilians-University of Munich,Butenandtstr.5,Building B,81377 Munich,Germany,Max Planck Institute for Biochemistry,D-82152 Martinsried,Germany,and Nereus Pharmaceuticals,Inc.,10480 Wateridge Circle,San Diego,California;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号